Pliant Therapeutics will be cutting 45% of staffers as part of a “strategic restructuring of its workforce," the biotech announced after-hours May 1.
The move comes as the company looks to deal with the fallout of its recent bexotegrast study.
https://www.fiercebiotech.com/biotech/pliant-therapeutics-cuts-workforce-45-after-bexotegrast-trial-safety-woes